tradingkey.logo

ENDRA Life Sciences Inc

NDRA
4.990USD
-0.180-3.48%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
3.75MCap. mercado
PérdidaP/E TTM

ENDRA Life Sciences Inc

4.990
-0.180-3.48%

Más Datos de ENDRA Life Sciences Inc Compañía

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Información de ENDRA Life Sciences Inc

Símbolo de cotizaciónNDRA
Nombre de la empresaENDRA Life Sciences Inc
Fecha de salida a bolsaJun 28, 2017
Director ejecutivoMr. Alexander Y. Tokman
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 28
Dirección3600 Green Ct Ste 350
CiudadANN ARBOR
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal48105-2440
Teléfono17343350468
Sitio Webhttps://www.endrainc.com/
Símbolo de cotizaciónNDRA
Fecha de salida a bolsaJun 28, 2017
Director ejecutivoMr. Alexander Y. Tokman

Ejecutivos de ENDRA Life Sciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--
Mr. Richard Jacroux
Mr. Richard Jacroux
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: jue., 30 de oct
Actualizado: jue., 30 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Otro
76.62%
Accionistas
Accionistas
Proporción
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Otro
76.62%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
12.60%
Private Equity
9.95%
Investment Advisor
0.65%
Investment Advisor/Hedge Fund
0.44%
Corporation
0.06%
Otro
76.31%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
24
12.65K
1.08%
+1.88K
2025Q2
34
22.09K
2.99%
+12.79K
2025Q1
37
5.94K
0.98%
+652.00
2024Q4
38
889.00
0.17%
-4.90K
2024Q3
39
6.39K
8.81%
+5.79K
2024Q2
39
2.03K
9.18%
+1.72K
2024Q1
33
352.00
9.94%
+101.00
2023Q4
35
276.00
9.44%
+68.00
2023Q3
37
286.00
9.99%
+78.00
2023Q2
39
314.00
10.85%
+151.00
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
DiGiandomenico (Anthony)
5.44K
0.72%
+5.38K
+9125.42%
Jun 11, 2025
Geode Capital Management, L.L.C.
5.13K
0.68%
+594.00
+13.09%
Aug 31, 2025
UBS Financial Services, Inc.
4.70K
0.62%
+4.70K
--
Jun 30, 2025
The Vanguard Group, Inc.
116.00
0.02%
--
--
Aug 31, 2025
S.H.N. Financial Investments Ltd
686.00
0.09%
+686.00
--
Jun 04, 2024
Northwestern Mutual Capital, LLC
35.00
0%
+35.00
--
Jun 30, 2025
Thornton (Michael Milos)
20.00
0%
--
--
Mar 24, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Fecha
Tipo
Relación
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Dec 06, 2022
Merger
20→1
Dec 06, 2022
Merger
20→1
Ver más
KeyAI